Preparation method of 5,6-dihydropyridine-2 (1H)-one derivative

A technology of dihydropyridine and derivatives, which is applied in the field of medicinal chemistry and can solve the problems of many reaction steps, high price, cumbersome operation, etc.

Active Publication Date: 2020-05-19
XINFA PHARMA
View PDF5 Cites 2 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0013] The iodide raw material 1-(4-iodophenyl)-2-piperidone and 1-(4-iodophenyl)-3,3-dichloropiperidine- The price of 2-ketone is high, and there are many reaction steps, cumbersome operation and high cost; the selectivity of phosphorus pentachloride dichlorination reaction in synthetic route 1 is low, the amount of phosphorus-containing wastewater is large, the total yield is low, and it has no practical application value ; Synthetic ro

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Preparation method of 5,6-dihydropyridine-2 (1H)-one derivative
  • Preparation method of 5,6-dihydropyridine-2 (1H)-one derivative
  • Preparation method of 5,6-dihydropyridine-2 (1H)-one derivative

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0098] Example 1: Preparation of N-(5-hydroxyl-n-pentanoyl)-N'-acetyl p-phenylenediamine (Ⅲ)

[0099] In a 1000 ml four-neck flask connected with a stirrer, a thermometer, and a condenser tube, add 350 grams of toluene, 30 grams of N,N-dimethylformamide, 75.0 grams (0.5 moles) of para-acetamidoaniline (II), 70.0 Gram (0.7 moles) δ-valerolactone, heating, 110-115 ℃ of stirring reaction 4 hours, cooling to 20-25 ℃, filtering, 30 gram of toluene washing filter cakes, drying, obtains 115.8 gram of N-(5-hydroxyl N-pentanoyl)-N'-acetyl-p-phenylenediamine (Ⅲ), the yield is 92.6%, and the liquid phase purity is 99.5%.

Embodiment 2

[0100] Example 2: Preparation of N-(5-hydroxy-n-pentanoyl)-N'-acetyl p-phenylenediamine (Ⅲ)

[0101] To a 500 ml four-necked flask connected with a stirrer, a thermometer, and a condenser tube, add 250 g of N,N-dimethylformamide, 75.0 g (0.5 mole) of p-acetamidoaniline (II), 70.0 g (0.7 mole ) δ-valerolactone, heated, stirred at 115-120°C for 4 hours, cooled to 50-70°C, recovered N,N-dimethylformamide by distillation under reduced pressure, and recrystallized the residue with 400 grams of 75% methanol , filter, 30 grams of water wash the filter cake, dry to obtain 118.6 grams of N-(5-hydroxyl n-valeryl)-N'-acetyl p-phenylenediamine (Ⅲ), the yield is 94.9%, and the liquid phase purity is 99.9% %.

Embodiment 3

[0102] Example 3: Preparation of 4-(piperidin-2-one-1-yl)-N-acetylaniline (Ⅴ)

[0103] In the 500 milliliter four-neck flask that is connected with agitator, thermometer, reflux condenser and connected with 30wt% sodium hydroxide aqueous solution absorption device, add 150 grams of 1,2-ethylene dichloride, 25.0 grams (0.1 moles) implement N-(5-hydroxyl n-pentanoyl)-N'-acetyl p-phenylenediamine (Ⅲ) obtained by the method of example 2 is heated, and kept between 40-50°C of internal temperature, to which 23.8 grams (0.2 mol) of thionyl chloride and 50 g of 1,2-dichloroethane, the solution was added dropwise in 2 hours, and thereafter, the reaction was stirred at 55-60° C. for 3 hours. Cool to 30°C, change to a vacuum distillation device, and recover 1,2-dichloroethane and excess thionyl chloride by vacuum distillation (for the next batch reaction after analyzing the content), after the distillation is completed, cool to 20- At 25°C, the resulting residue N-(5-chloro-n-valeryl)-N...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention provides a preparation method of a 5,6-dihydropyridine-2 (1H)-one derivative, and particularly relates to a 1-(piperidine-2-keto-1-yl)-4-(5,6-dihydro-3-R substituent pyridine-2 (1H)-keto-1-yl) benzene preparation method, wherein the R substituent is chlorine or morpholine-4-yl. According to the invention, p-acetamido aniline is used as a raw material, and amidation with delta-valerolactone, halogenation with a halogenation reagent or sulfonylation with sulfonyl chloride, condensation, deacetylation, amidation with 2,2-dichloro-delta-valerolactone, halogenation with a halogenationreagent or sulfonylation with sulfonyl chloride, condensation elimination or condensation elimination substitution in the presence of morpholine are performed to obtain the target product. Accordingto the invention, the raw materials used in the preparation method are cheap, easy to obtain and low in cost; the process operation is simple, reaction conditions are easy to realize, the wastewater yield is low, and safety and greenness are realized; and the reaction selectivity of each step is high, the product yield and purity are high, and industrial production is facilitated.

Description

technical field [0001] The present invention relates to a preparation method of 5,6-dihydropyridine-2(1H)-one derivatives, specifically 1-(piperidin-2-one-1-yl)-4-(5,6-di The preparation method of hydrogen-3-R substituent pyridin-2(1H)-one-1-yl)benzene belongs to the technical field of medicinal chemistry. Background technique [0002] Apixaban (Apixaban), chemical name l-(4-methoxyphenyl)-7-oxo-6-[4-(2-oxopiperidin-1-yl)phenyl]-4 ,5,6,7-tetrahydro-1H-pyrazolo[3,4-c]pyridine-3-carboxamide is a novel direct factor Xa inhibitor jointly developed by Bristol-Myers Squibb and Pfizer , was approved by the European Union and the US FDA in March 2011 and December 2012, respectively. The trade name is Eliquis, which is used to prevent venous thromboembolism (VTE) and atrial fibrillation in adult patients undergoing hip or knee replacement. Among them, 1-(piperidin-2-one-1-yl)-4-(5,6-dihydro-3-chloro Pyridine-2(1H)-one-1-yl)benzene(I1) and 1-(piperidin-2-one-1-yl)-4-(5,6-dihydro-3-...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
IPC IPC(8): C07D401/10
CPCC07D401/10
Inventor 戚聿新刘月盛钱余峰唐兆宁
Owner XINFA PHARMA
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products